A.E.C. Korst

789 citations

20 papers · 681 indexed · h-index 16

Impact in

Oncology top 10%
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
Cancer Research

Papers in ⓘ

Pharmaceutical Science 3
- Chemical Reactions and Isotopes 2
Radiology, Nuclear Medicine and Imaging 10
- Effects of Radiation Exposure 9

Co-authors: Jan B. Vermorken (13 shared papers)Filip Lardon (10 shared papers)Bea Pauwels (9 shared papers)Hilde Lambrechts (9 shared papers)G Pattyn (9 shared papers)W. J. F. van der Vijgh (4 shared papers)Marc Baay (2 shared papers)Corien Eeltink (2 shared papers)
Journals: European Journal of Cancer (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)British Journal of Cancer (1 paper)Radiation Research (1 paper)
Partner nations: Belgium Netherlands Australia

In The Last Decade

A.E.C. Korst

20 papers receiving 664 citations

Peers

Countries citing papers authored by A.E.C. Korst

Since Specialization

Citations

This map shows the geographic impact of A.E.C. Korst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.E.C. Korst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.E.C. Korst more than expected).

Fields of papers citing papers by A.E.C. Korst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.E.C. Korst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.E.C. Korst. The network helps show where A.E.C. Korst may publish in the future.

Co-authors

The 25 scholars most cited alongside A.E.C. Korst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A.E.C. Korst Line = papers co-authored together A.E.C. Korst links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combined Modality Therapy of Gemcitabine and Radiation The Oncologist ·Bea Pauwels, A.E.C. Korst, Filip Lardon, Jan B. Vermorken	2005	123
2	Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies Cancer Chemotherapy and Pharmacology ·Bea Pauwels, A.E.C. Korst, Christel M. J. de Pooter, G Pattyn, Hilde Lambrechts, Marc Baay, Filip Lardon, Jan B. Vermorken	2003	121
3	Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro International Journal of Radiation OncologyBiologyPhysics ·Bea Pauwels, A.E.C. Korst, G Pattyn, Hilde Lambrechts, Dirk R. Van Bockstaele, Katrien Vermeulen, Marc Lenjou, Christel M. J. de Pooter, Jan B. Vermorken, Filip Lardon	2003	63
4	Pharmacokinetics of amifostine and its metabolites in patients European Journal of Cancer ·A.E.C. Korst, Corien Eeltink, Jan B. Vermorken, W.J.F. van der Vijgh	1997	44
5	Amifostine (Ethyol®): Pharmacokinetic and Pharmacodynamic Effects in vivo European Journal of Cancer ·W. J. F. van der Vijgh, A.E.C. Korst	1996	40
6	The analysis of ifosfamide and its metabolites (review). PubMed ·G.P. Kaijser, A.E.C. Korst, J. H. Beijnen, A. Bult, W.J.M. Underberg	1993	34
7	In vitro interaction between Ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects British Journal of Cancer ·Cindy Simoens, A.E.C. Korst, C. M. J. De Pooter, Hilde Lambrechts, G Pattyn, Glynn Faircloth, Filip Lardon, Jan B. Vermorken	2003	30
8	Influence of amifostine on the pharmacokinetics of cisplatin in cancer patients. PubMed ·A.E.C. Korst, M L van der Sterre, H.E. Gall, A M Fichtinger-Schepman, Jan B. Vermorken, W J van der Vijgh	1998	28
9	Unraveling the Mechanism of Radiosensitization by Gemcitabine: The Role of TP53 Radiation Research ·Bea Pauwels, A.E.C. Korst, Veronique Andriessen, Marc Baay, G Pattyn, Hilde Lambrechts, Christel M. J. de Pooter, Filip Lardon, Jan B. Vermorken	2005	24
10	The radiosensitising effect of gemcitabine and the influence of the rescue agent amifostine in vitro European Journal of Cancer ·Bea Pauwels, A.E.C. Korst, C. M. J. De Pooter, Hilde Lambrechts, G Pattyn, Filip Lardon, Jan B. Vermorken	2003	23
11	The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro Cancer Chemotherapy and Pharmacology ·Bea Pauwels, A.E.C. Korst, Hilde Lambrechts, G Pattyn, Christel M. J. de Pooter, Filip Lardon, Jan B. Vermorken	2005	23
12	Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro Cancer Chemotherapy and Pharmacology ·Cindy Simoens, Jan B. Vermorken, A.E.C. Korst, Bea Pauwels, Christel M. J. de Pooter, G Pattyn, Hilde Lambrechts, F. Breillout, Filip Lardon	2005	21
13	Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient Cancer Chemotherapy and Pharmacology ·A.E.C. Korst, Helen Gall, J. B. Vermorken, W. J. F. van der Vijgh	1996	20
14	Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire® core Journal of Controlled Release ·Els Mehuys, Jean Paul Remon, A.E.C. Korst, Lucas Van Bortel, Raf Mols, Patrick Augustijns, Christopher J. H. Porter, Chris Vervaet	2005	20
15	The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines BMC Cancer ·Bea Pauwels, A.E.C. Korst, G Pattyn, Hilde Lambrechts, J. A. E. Kamphuis, Christel MJ De Pooter, Godefridus J. Peters, Filip Lardon, Jan B. Vermorken	2006	18
16	Pharmacokinetics of cisplatin with and without amifostine in tumour-bearing nude mice European Journal of Cancer ·A.E.C. Korst, Epie Boven, Marianne L. T. van der Sterre, Anne Marie J. Fichtinger-Schepman, W. J. F. van der Vijgh	1998	17
17	High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma Journal of Chromatography B Biomedical Sciences and Applications ·A.E.C. Korst, Jan B. Vermorken, W.J.F van der Vijgh	1997	15
18	Pharmacokinetics of carboplatin with and without amifostine in patients with solid tumors. PubMed ·A.E.C. Korst, M L van der Sterre, Corien Eeltink, Anne Marie J. Fichtinger-Schepman, Jan B. Vermorken, W J van der Vijgh	1997	14
19	Influence of single and multiple doses of maifostine on the efficacy and the pharmacokinetics of carboplatin in mice Bulletin du Cancer ·A.E.C. Korst, Epie Boven, Marianne L. T. van der Sterre, Anne Marie J. Fichtinger-Schepman, W. J. F. van der Vijgh	1997	2
20	The concentration-dependency of the radiosensitising effect of gemcitabine and the influence of the rescue agent amifostine in vitro European Journal of Cancer ·Bea Pauwels, A.E.C. Korst, Christel De Pooter, G Pattyn, Hilde Lambrechts, Filip Lardon, Jan B. Vermorken	2001	1

About A.E.C. Korst

A.E.C. Korst is a scholar working on Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 20 papers that have together received 681 indexed citations. Recurring topics across this work include Effects of Radiation Exposure (9 papers), Cancer therapeutics and mechanisms (6 papers), DNA Repair Mechanisms (5 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Carcinogens and Genotoxicity Assessment (4 papers), Lung Cancer Treatments and Mutations (3 papers), Chemical Reactions and Isotopes (2 papers) and Ion channel regulation and function (2 papers). The work is most often cited by research in Oncology (264 citations), Cancer Research (89 citations), Radiology, Nuclear Medicine and Imaging (116 citations), Pharmaceutical Science (30 citations) and Pulmonary and Respiratory Medicine (158 citations). A.E.C. Korst has collaborated with scholars based in Belgium, Netherlands and Australia. Frequent co-authors include Jan B. Vermorken, Filip Lardon, Bea Pauwels, Hilde Lambrechts, G Pattyn, W. J. F. van der Vijgh, Marc Baay, Corien Eeltink, A. Bult and J. H. Beijnen. Their work appears in journals such as European Journal of Cancer, Cancer Chemotherapy and Pharmacology, International Journal of Radiation Oncology*Biology*Physics, British Journal of Cancer and Radiation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact